Google, Amazon, and other companies have already invested overwhelming intellectual capital in letting people interact with smart-home devices through voice control. “Voice is really great for a lot of things,” says Marks. “But it’s missing the kind of key things that a mouse brought to computers—spatial input and easy selection and things like that. So I’ve been working on trying to bring that kind of thing into the ambient computing world.” He mentions another source of inspiration: Star Trek’s Tricorder. … [Read more...] about Google’s secretive ATAP lab is imagining the future of smart devices
Silicon valley banking
For Hansson, that is the essential difference between Hey and its competitors. “Email is getting turned into the [Facebook] News Feed. It’s an editorialized inbox that the likes of Google have designed for you,” he says. Reporting by The Markup earlier this year, for example, found that some Democratic presidential candidates’ email updates were getting sent to spam, while others were reliably claiming prime inbox territory. “It’s the same power that Facebook sits on; it’s their moral prerogative whether to use it. I don’t think that’s good. I think it’s completely dystopian. … [Read more...] about Meet the Big Tech critic behind Hey, Basecamp’s radical new email platform
“Seeing the current market situation, we would advise investors to invest in Bharat ETF Bond for the long term because the return is predictable and also earlier bonds have delivered annualised return in the range of 14-18 percent. Additionally, it has a high credit rating and a good tool for diversification into debt,” Ajit Mishra, VP - Research, Religare Broking told Moneycontrol. … [Read more...] about Rossari Biotech IPO, Bharat Bond ETF & Yes Bank FPO: Where should investors put their money?
For those who don’t remember the case, the context here is the RBI action to write down Yes Bank’s AT1 bonds as part of a rescue plan. A stock exchange clarification from Yes Bank’s RBI-appointed administrator, Prashant Kumar, in March said the AT1 bondholders will get nothing as per the condition of the reconstruction scheme. This, logically, came as a jolt to many investors, both retail and institutional. … [Read more...] about Banking Central: RBI ko gussa kyon aata hai?
Specialty chemicals manufacturer Rossari Biotech has become the first company to launch an initial public offering (IPO) during the coronavirus lockdown and the second after SBI Cards this year. The company was to launch its IPO in March but unfavourable market conditions forced it to put off the plan. … [Read more...] about Analysts say subscribe to Rossari Biotech IPO despite high valuation, here is why